Clinical trials
Phase 3 Tobacco Use Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 6 |
| Mayo Clinic | 5 |
| National Institute on Drug Abuse (NIDA) | 3 |
| Queen Mary University of London | 3 |
| University of California, San Diego | 3 |
| University of Pennsylvania | 3 |
| Butler Hospital | 2 |
| Duke University | 2 |
| McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. | 2 |
| Medical University of South Carolina | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tobacco Use Disorder | 52 |
| Acquired Immunodeficiency Syndrome | 2 |
| HIV Infections | 2 |
| Alcoholism | 1 |
| Body Weight | 1 |
| Cardiovascular Diseases | 1 |
| Cocaine-Related Disorders | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Major Depressive Disorder | 1 |
| Marijuana Use | 1 |
Trials
Showing 26 to 50 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.